Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
Clinical Pathway for Pancreatic Enzyme Replacement Therapy (PERT) in Children with or at Risk for Exocrine Pancreatic Insufficiency (EPI)
PERT Dosing Recommendations
Dosing Guidance for Oral, Bolus, and Continuous Tube Feeds
Consider consult with Nutrition or PERT expert when dosing enzymes to determine the best method for use and for dose titration recommendations. PERT Formulations
PERT for Oral Feeds – Use Enteric Coated Formulation
Child's Age | Age-based Dosing Recommendations | Focused Guidance About Administration | Titration |
---|---|---|---|
Premature and Full-term Infants ≤ 12 mos |
|
|
|
Children and Adolescents |
|
|
|
PERT for Tube Feeding – Bolus Feeds
Enteric Coated Enzyme |
|
|
---|---|---|
|
|
|
Non-enteric Coated Enzyme (Viokace) |
|
|
RELiZORB |
|
|
PERT for Tube Feeding - Continuous/Overnight Feeds
RELiZORB |
|
|
---|---|---|
Non-enteric Coated Enzyme (Viokace) |
|
|
Enteric Coated Enzyme |
|
|